Patent Assignment
Reel/Frame 075069/0879
Release of Security Interest
Recorded: 2026-06-24
Pages: 10
Assignor
OXFORD FINANCE LLC
Executed: 2026-06-24
Assignee
CENTESSA PHARMACEUTICALS (UK) LIMITED
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
Covered Properties
(34)
Alpha Substituted Stat Inhibitors and Compositions Thereof
Application:
17/909,179 →
Publication:
US 2023/0137956
Stat Inhibitory Compounds and Compositions
Application:
17/909,153 →
Publication:
US 2023/0159445
Heterocycle Containing Stat Inhibitors and Compositions
Application:
17/909,162 →
Publication:
US 2023/0150946
Stat Inihibitory Compounds and Compositions
Application:
18/024,159 →
Publication:
US 2023/0265055
Antigen Binding Molecules That Bind Light
Antigen Binding Molecules That Bind Light
Application:
18/480,379 →
Publication:
US 2024/0294655
Anti Bdca-2 Antibodies
Application:
17/665,239 →
Publication:
US 2022/0162322
Anti-Pd-L1 Antibodies
Application:
17/627,517 →
Publication:
US 2022/0356255
Anti C-Met Antibodies
Activatable Bispecific Antibodies Comprising a Linker Between the Two Binding Domains Which Is a Human Immunoglobulin Hinge Region, or a Variant Thereof, and Uses Thereof
Application:
17/610,899 →
Publication:
US 2023/0192899
CD47 Binding Agents
Treating Cancer Using Nucleic Acid Encoding an Anti-CD47 Binding Agent
Application:
17/849,101 →
Publication:
US 2022/0332819
Anti-CD47 Binding Agents
Application:
18/893,023 →
Publication:
US 2025/0109202
Activatable Bispecific Anti-CD47 and Anti-Pd-L1 Proteins and Uses Thereof
Application:
18/778,061 →
Publication:
US 2025/0002585
Substituted Macrocycles as Orexin-2 Receptor Agonists
Application:
18/024,236 →
Publication:
US 2023/0331720
Medium- or Macro-Cyclic Benzyl-Substituted Heterocycle Derivatives and Related Uses
Application:
18/817,943 →
Publication:
US 2025/0236629
Bicyclic-Heterocycle Derivatives and Their Uses as Orexin-2 Receptor Agonists
Bicyclic-Heterocycle Derivatives and Related Uses
Application:
18/818,172 →
Publication:
US 2025/0100968
2-(3-Ethynylbenzyl)-Substituted Heterocycle Derivatives and Related Uses
Peptide Derivatives and Related Uses as Orexin Agonists
Application:
18/438,178 →
Publication:
US 2024/0360175
Compounds and Their Use for the Treatment of ALPHA1-Antitrypsin Deficiency
Compounds and Their Use for the Treatment of ALPHA1-Antitrypsin Deficiency
Application:
17/839,225 →
Publication:
US 2023/0102488
Compounds and Their Use for the Treatment of ALPHA1-Antitrypsin Deficiency
Compounds and Their Use for the Treatment of ALPHA1-Antitrypsin Deficiency
Compounds and Their Use for the Treatment of ALPHA1-Antitrypsin Deficiency
4-((6-Oxopyrimidin-1(6H)-Yl)Methyl)Benzoic Acid as an Inducer of Z A1AT Secretion for Treating Aatd
Compositions and their Use for the Treatment of A1-Antitrypsin Deficiency
Compounds and Their Use for the Treatment of ALPHA1-Antitrypsin Deficiency
Antigen Binding Molecules That Bind Light
Antigen Binding Molecules That Bind Light
Anti C-Met Antibodies
Anti-CD47 Antibody Molecules
Method of Using Anti-CD47 Antibody Molecules
Compounds and Their Use for the Treatment of ALPHA1-Antitrypsin Deficiency
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 29, 2020
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN TWO LIMITED
Reel/Frame 053913/0676 →
Security Interest
Oct 4, 2021
From: APCINTEX LIMITED; JANPIX LIMITED; CAPELLA BIOSCIENCE LTD; LOCKBODY THERAPEUTICS LTD
To: COCOON SA LLC
Reel/Frame 057710/0082 →
Assignment of Assignor's Interest
Jan 18, 2022
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN SIX LIMITED
Reel/Frame 058682/0555 →
Change of Name
Jan 18, 2022
From: ULTRAHUMAN SIX LIMITED
To: LOCKBODY THERAPEUTICS LTD
Reel/Frame 058682/0776 →
Change of Registered Office Address
May 20, 2022
From: ULTRAHUMAN TWO LIMITED
To: ULTRAHUMAN TWO LIMITED
Reel/Frame 060135/0770 →
Change of Address
May 20, 2022
From: LOCKBODY THERAPEUTICS LTD
To: LOCKBODY THERAPEUTICS LTD
Reel/Frame 061603/0778 →
Assignment of Assignor's Interest
Nov 3, 2022
From: FINALY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 061648/0733 →
Change of Address
Nov 3, 2022
From: ULTRAHUMAN FOUR LIMITED
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 061879/0735 →
Assignment of Assignor's Interest
Nov 11, 2022
From: RAMSDEN, NIGEL, DR.; FOX, DAVID JOHN, DR.; HUNTINGTON, JAMES ANDREW; TOMLINSON, JAMES MICHAEL, DR.
To: Z FACTOR LIMITED
Reel/Frame 061931/0427 →
Assignment of Assignor's Interest
Nov 11, 2022
From: RAMSDEN, NIGEL, DR.; FOX, DAVID JOHN, DR.; HUNTINGTON, JAMES ANDREW; TOMLINSON, JAMES MICHAEL, DR.
To: Z FACTOR LIMITED
Reel/Frame 061931/0442 →
Corrective Assignment to Correct the Assignor's Name Previously Recorded at Reel: 061648 Frame: 0733. Assignor(S) Hereby Confirms the Assignment .
Dec 14, 2022
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 062119/0110 →
Assignment of Assignor's Interest
Jan 10, 2023
From: FLECK, ROMAN; PROUDFOOT, JOHN; OMEARA, JEFF; GNANASEKARAN, KRISHNA KUMAR
To: JANPIX LIMITED
Reel/Frame 062326/0859 →
Assignment of Assignor's Interest
Jan 10, 2023
From: FLECK, ROMAN; PROUDFOOT, JOHN; GNANASEKARAN, KRISHNA KUMAR; GUNNING, PATRICK THOMAS
To: JANPIX LIMITED
Reel/Frame 062331/0698 →
Assignment of Assignor's Interest
Jan 10, 2023
From: FLECK, ROMAN; PROUDFOOT, JOHN; GNANASEKARAN, KRISHNA KUMAR; GUNNING, PATRICK THOMAS
To: JANPIX LIMITED
Reel/Frame 062330/0764 →
Assignment of Assignor's Interest
Jan 18, 2023
From: HOLMES, STEVE
To: CAPELLA BIOSCIENCE LTD.
Reel/Frame 062415/0257 →
Assignment of Assignor's Interest
Jan 18, 2023
From: HOLMES, STEVE
To: CAPELLA BIOSCIENCE LTD.
Reel/Frame 062415/0243 →
Corrective Assignment to Correct the the List of All Inventors Names and Execution Dates Previously Recorded at Reel: 062330 Frame: 0764. Assignor(S) Hereby Confirms the Assignment.
May 15, 2023
From: FLECK, ROMAN; PROUDFOOT, JOHN; OMEARA, JEFF; GUNNING, PATRICK THOMAS
To: JANPIX LIMITED
Reel/Frame 063660/0525 →
Assignment of Assignor's Interest
May 16, 2023
From: FLECK, ROMAN; PROUDFOOT, JOHN; OMEARA, JEFF; GUNNING, PATRICK THOMAS
To: JANPIX LIMITED
Reel/Frame 063659/0361 →
Assignment of Assignor's Interest
Aug 4, 2023
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN SIX LIMITED
Reel/Frame 064495/0435 →
Change of Address
Aug 4, 2023
From: LOCKBODY THERAPEUTICS LTD
To: LOCKBODY THERAPEUTICS LTD
Reel/Frame 064501/0584 →
Change of Name
Aug 4, 2023
From: ULTRAHUMAN SIX LIMITED
To: LOCKBODY THERAPEUTICS LTD
Reel/Frame 064495/0453 →
Assignment of Assignor's Interest
Aug 28, 2023
From: PORTER, RODERICK
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0849 →
Assignment of Assignor's Interest
Aug 28, 2023
From: SPENDIFF, MATTHEW; BUCKNELL, SARAH; ZAWODNY, WOJCIECH
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0819 →
Assignment of Assignor's Interest
Aug 28, 2023
From: GIBSON, KARL
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0781 →
Assignment of Assignor's Interest
Aug 28, 2023
From: HUMPHRIES, PAUL
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0767 →